These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 8979247)
21. Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: effects of the oxytocin antagonist atosiban. Bossmar T; Akerlund M; Fantoni G; Szamatowicz J; Melin P; Maggi M Am J Obstet Gynecol; 1994 Dec; 171(6):1634-42. PubMed ID: 7802081 [TBL] [Abstract][Full Text] [Related]
22. Conformational aspects of differences in requirements for oxytocin and vasopressin receptors. Oldziej S; Ciarkowski J; Liwo A; Shenderovich MD; Grzonka Z J Recept Signal Transduct Res; 1995; 15(1-4):703-13. PubMed ID: 8903974 [TBL] [Abstract][Full Text] [Related]
23. Effects of arginine vasopressin and oxytocin on glucagon release from clonal alpha-cell line In-R1-G9: involvement of V1b receptors. Yibchok-anun S; Hsu WH Life Sci; 1998; 63(21):1871-8. PubMed ID: 9825765 [TBL] [Abstract][Full Text] [Related]
24. Oxytocin in the medial prefrontal cortex attenuates anxiety: Anatomical and receptor specificity and mechanism of action. Sabihi S; Dong SM; Maurer SD; Post C; Leuner B Neuropharmacology; 2017 Oct; 125():1-12. PubMed ID: 28655609 [TBL] [Abstract][Full Text] [Related]
25. The distribution of enzymes destroying oxytocin and vasopressin in human placentae. HOOPER KC; JESSUP DC J Physiol; 1959 Jun; 146(3):539-49. PubMed ID: 13665676 [No Abstract] [Full Text] [Related]
26. Historadioautographic localisation of oxytocin and vasopressin binding sites in the central nervous system of the merione (Meriones shawi). Rabhi M; Stoeckel ME; Calas A; Freund-Mercier MJ Brain Res Bull; 1999 Jan; 48(2):147-63. PubMed ID: 10230706 [TBL] [Abstract][Full Text] [Related]
27. Oxytocin and vasopressin receptor distributions in a solitary and a social species of tuco-tuco (Ctenomys haigi and Ctenomys sociabilis). Beery AK; Lacey EA; Francis DD J Comp Neurol; 2008 Apr; 507(6):1847-59. PubMed ID: 18271022 [TBL] [Abstract][Full Text] [Related]
28. Selective blockade of oxytocin and vasopressin V(1a) receptors in anaesthetised rats: evidence that activation of oxytocin receptors rather than V(1a) receptors increases sodium excretion. Shirley DG; Walter MF; Keeler BD; Waters NJ; Walter SJ Nephron Physiol; 2011; 117(3):p21-6. PubMed ID: 21071981 [TBL] [Abstract][Full Text] [Related]
29. Tetrahydroquinoline sulfonamides as vasopressin 1b receptor antagonists. Scott JD; Miller MW; Li SW; Lin SI; Vaccaro HA; Hong L; Mullins DE; Guzzi M; Weinstein J; Hodgson RA; Varty GB; Stamford AW; Chan TY; McKittrick BA; Greenlee WJ; Priestley T; Parker EM Bioorg Med Chem Lett; 2009 Nov; 19(21):6018-22. PubMed ID: 19800231 [TBL] [Abstract][Full Text] [Related]
30. Oxytocin and vasopressin stimulate anion secretion by human and porcine vas deferens epithelia. Hagedorn TM; Carlin RW; Schultz BD Biol Reprod; 2007 Sep; 77(3):416-24. PubMed ID: 17442854 [TBL] [Abstract][Full Text] [Related]
31. The behavioral effect of vasopressin in the ventral hippocampus is antagonized by an oxytocin receptor antagonist. Paban V; Alescio-Lautier B; Devigne C; Soumireu-Mourat B Eur J Pharmacol; 1998 Nov; 361(2-3):165-73. PubMed ID: 9865505 [TBL] [Abstract][Full Text] [Related]
32. Conformationally constrained o-tolylpiperazine camphorsulfonamide oxytocin antagonists. Structural modifications that provide high receptor affinity and suggest a bioactive conformation. Williams PD; Ball RG; Clineschmidt BV; Culberson JC; Erb JM; Freidinger RM; Pawluczyk JM; Perlow DS; Pettibone DJ; Veber DF Bioorg Med Chem; 1994 Sep; 2(9):971-85. PubMed ID: 7712132 [TBL] [Abstract][Full Text] [Related]
33. Ventral striatopallidal oxytocin and vasopressin V1a receptors in the monogamous prairie vole (Microtus ochrogaster). Lim MM; Murphy AZ; Young LJ J Comp Neurol; 2004 Jan; 468(4):555-70. PubMed ID: 14689486 [TBL] [Abstract][Full Text] [Related]
34. Oxytocin inhibits the rat medullary dorsal horn Sp5c/C1 nociceptive transmission through OT but not V García-Boll E; Martínez-Lorenzana G; Condés-Lara M; González-Hernández A Neuropharmacology; 2018 Feb; 129():109-117. PubMed ID: 29169960 [TBL] [Abstract][Full Text] [Related]
35. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents. Manning M; Stoev S; Chini B; Durroux T; Mouillac B; Guillon G Prog Brain Res; 2008; 170():473-512. PubMed ID: 18655903 [TBL] [Abstract][Full Text] [Related]
36. Oxytocin, vasopressin, and social recognition in mammals. Bielsky IF; Young LJ Peptides; 2004 Sep; 25(9):1565-74. PubMed ID: 15374658 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and characterization of fluorescent antagonists and agonists for human oxytocin and vasopressin V(1)(a) receptors. Terrillon S; Cheng LL; Stoev S; Mouillac B; Barberis C; Manning M; Durroux T J Med Chem; 2002 Jun; 45(12):2579-88. PubMed ID: 12036367 [TBL] [Abstract][Full Text] [Related]
38. Neural correlates of mating system diversity: oxytocin and vasopressin receptor distributions in monogamous and non-monogamous Eulemur. Grebe NM; Sharma A; Freeman SM; Palumbo MC; Patisaul HB; Bales KL; Drea CM Sci Rep; 2021 Feb; 11(1):3746. PubMed ID: 33580133 [TBL] [Abstract][Full Text] [Related]
39. The emergence of the vasopressin and oxytocin hormone receptor gene family lineage: Clues from the characterization of vasotocin receptors in the sea lamprey (Petromyzon marinus). Mayasich SA; Clarke BL Gen Comp Endocrinol; 2016 Jan; 226():88-101. PubMed ID: 26764211 [TBL] [Abstract][Full Text] [Related]
40. Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Huber D; Veinante P; Stoop R Science; 2005 Apr; 308(5719):245-8. PubMed ID: 15821089 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]